Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions

References

• Ballard, E. D., Ionescu, D. F., Vande Voort, J. L., Niciu, M. J., Richards, E. M., Luckenbaugh, D. A., Brutsché, N. E., Ameli, R., Furey, M. L., & Zarate, C. A. Jr., (2014). Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety. Journal of Psychiatric Research, 58, 161–166. doi:10.1016/j.jpsychires.2014.07.027
   PubMed Web of Science ®Google Scholar
• Ballard, E. D., Wills, K., Lally, N., Richards, E. M., Luckenbaugh, D. A., Walls, T., Ameli, R., Niciu, M. J., Brutsche, N. E., Park, L., & Zarate, C. A. Jr., (2017). Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. Journal of Affective Disorders, 218, 195–200. doi:10.1016/j.jad.2017.04.057
   PubMed Web of Science ®Google Scholar
• Beck, A. T., Kovacs, M., & Weissman, A. (1979). Assessment of suicidal intention: The scale for suicide ideation. Journal of Consulting and Clinical Psychology, 47(2), 343–352. doi:10.1037/0022-006X.47.2.343
   PubMed Web of Science ®Google Scholar
• Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351–354. doi:10.1016/S0006-3223(99)00230-9
   PubMed Web of Science ®Google Scholar
• Brown, G. K., Ten Have, T., Henriques, G. R., Xie, S. X., Hollander, J. E., & Beck, A. T. (2005). Cognitive therapy for the prevention of suicide attempts: A randomized controlled trial. Journal of the American Medical Association, 294(5), 563–570. doi:10.1001/jama.294.5.563
   PubMed Web of Science ®Google Scholar
• Canuso, C. M., Singh, J. B., Fedgchin, M., Alphs, L., Lane, R., Lim, P., Pinter, C., Hough, D., Sanacora, G., Manji, H., & Drevets, W. C. (2018). Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: Results of a double-blind, randomized, placebo-controlled study. The American Journal of Psychiatry, 175(7), 620–630. doi:10.1176/appi.ajp.2018.17060720
   PubMed Web of Science ®Google Scholar
• Cao, B., Park, C., Subramaniapillai, M., Lee, Y., Iacobucci, M., Mansur, R. B., Zuckerman, H., Phan, L., & McIntyre, R. S. (2019). The efficacy of vortioxetine on anhedonia in patients with major depressive disorder. Frontiers in Psychiatry, 10, 17. doi:10.3389/fpsyt.2019.00017
   PubMed Web of Science ®Google Scholar
• Cavanagh, J. T., Carson, A. J., Sharpe, M., & Lawrie, S. M. (2003). Psychological autopsy studies of suicide: A systematic review. Psychological Medicine, 33(3), 395–405. doi:10.1017/S0033291702006943
   PubMed Web of Science ®Google Scholar
• Chen, M.-H., Lin, W.-C., Tu, P.-C., Li, C.-T., Bai, Y.-M., Tsai, S.-J., & Su, T.-P. (2019). Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: A double-blind, placebo-controlled, randomized, longitudinal resting fMRI study. Journal of Affective Disorders, 259, 15–20. doi:10.1016/j.jad.2019.08.022
   PubMed Web of Science ®Google Scholar
• Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013). Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis. British Medical Journal, 346, f3646. doi:10.1136/bmj.f3646
   PubMed Web of Science ®Google Scholar
• Delfino, R. S., Del-Porto, J. A., Surjan, J., Magalhães, E., Sant, L. C. D., Lucchese, A. C., Tuena, M. A., Nakahira, C., Fava, V. A. R., Steglich, M. S., Barbosa, M. G., Sarin, L. M., & Lacerda, A. L. T. (2021). Comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression. Journal of Affective Disorders, 278, 515–518. doi:10.1016/j.jad.2020.09.056
   PubMed Web of Science ®Google Scholar
• Dold, M., Bartova, L., Fugger, G., Kautzky, A., Souery, D., Mendlewicz, J., Papadimitriou, G. N., Dikeos, D., Ferentinos, P., Porcelli, S., Serretti, A., Zohar, J., Montgomery, S., & Kasper, S. (2018). Major depression and the degree of suicidality: Results of the European group for the study of resistant depression (GSRD). The International Journal of Neuropsychopharmacology, 21(6), 539–549. doi:10.1093/ijnp/pyy009
   PubMed Web of Science ®Google Scholar
• Ducasse, D., Loas, G., Dassa, D., Gramaglia, C., Zeppegno, P., Guillaume, S., Olié, E., & Courtet, P. (2018). Anhedonia is associated with suicidal ideation independently of depression: A meta-analysis. Depression and Anxiety, 35(5), 382–392. doi:10.1002/da.22709
   PubMed Web of Science ®Google Scholar
• Fawcett, J., Scheftner, W. A., Fogg, L., Clark, D. C., Young, M. A., Hedeker, D., & Gibbons, R. (1990). Time-related predictors of suicide in major affective disorder. The American Journal of Psychiatry, 147(9), 1189–1194.
   PubMed Web of Science ®Google Scholar
• Fugger, G., Bartova, L., Dold, M., Fabbri, C., Fanelli, G., Zanardi, R., Kautzky, A., Zohar, J., Souery, D., Mendlewicz, J., Montgomery, S., Rujescu, D., Serretti, A., & Kasper, S. (2022a). Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 114, 110480. doi:10.1016/j.pnpbp.2021.110480
   PubMed Web of Science ®Google Scholar
• Fugger, G., Bartova, L., Fabbri, C., Fanelli, G., Dold, M., Swoboda, M. M. M., Kautzky, A., Zohar, J., Souery, D., Mendlewicz, J., Montgomery, S., Rujescu, D., Serretti, A., & Kasper, S. (2022b). The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries. European Archives of Psychiatry and Clinical Neuroscience, 272(4), 715–727. doi:10.1007/s00406-021-01368-3
   PubMed Web of Science ®Google Scholar
• Fugger, G., Bartova, L., Fabbri, C., Fanelli, G., Zanardi, R., Dold, M., Kautzky, A., Rujescu, D., Souery, D., Mendlewicz, J., Zohar, J., Montgomery, S., Serretti, A., & Kasper, S. (2022c). The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs. Journal of Affective Disorders, 312, 225–234. doi:10.1016/j.jad.2022.06.004
   PubMedGoogle Scholar
• Gard, D. E., Gard, M. G., Kring, A. M., & John, O. P. (2006). Anticipatory and consummatory components of the experience of pleasure: A scale development study. Journal of Research in Personality, 40(6), 1086–1102. doi:10.1016/j.jrp.2005.11.001
   Web of Science ®Google Scholar
• Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62. doi:10.1136/jnnp.23.1.56
   PubMed Web of Science ®Google Scholar
• Hawton, K., Witt, K. G., Salisbury, T. L. T., Arensman, E., Gunnell, D., Hazell, P., Townsend, E., & van Heeringen, K. (2016). Psychosocial interventions following self-harm in adults: A systematic review and meta-analysis. The Lancet. Psychiatry, 3(8), 740–750. doi:10.1016/S2215-0366(16)30070-0
   PubMed Web of Science ®Google Scholar
• Kishimoto, T., Chawla, J. M., Hagi, K., Zarate, C. A., Kane, J. M., Bauer, M., & Correll, C. U. (2016). Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: A meta-analysis of efficacy, safety and time trajectories. Psychological Medicine, 46(7), 1459–1472. doi:10.1017/S0033291716000064
   PubMed Web of Science ®Google Scholar
• Lally, N., Nugent, A. C., Luckenbaugh, D. A., Ameli, R., Roiser, J. P., & Zarate, C. A. (2014). Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression. Translational Psychiatry, 4, e469. doi:10.1038/tp.2014.105
   PubMed Web of Science ®Google Scholar
• Lally, N., Nugent, A. C., Luckenbaugh, D. A., Niciu, M. J., Roiser, J. P., & Zarate, C. A. Jr., (2015). Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. Journal of Psychopharmacology, 29(5), 596–607. doi:10.1177/0269881114568041
   PubMed Web of Science ®Google Scholar
• Linehan, M. M., Comtois, K. A., Murray, A. M., Brown, M. Z., Gallop, R. J., Heard, H. L., Korslund, K. E., Tutek, D. A., Reynolds, S. K., & Lindenboim, N. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63(7), 757–766. doi:10.1001/archpsyc.63.7.757
   PubMed Web of Science ®Google Scholar
• Loas, G., Lefebvre, G., Rotsaert, M., & Englert, Y. (2018). Relationships between anhedonia, suicidal ideation and suicide attempts in a large sample of physicians. PLOS One, 13(3), e0193619. doi:10.1371/journal.pone.0193619
   PubMed Web of Science ®Google Scholar
• McIntyre, R. S., Loft, H., & Christensen, M. C. (2021). Efficacy of vortioxetine on anhedonia: Results from a pooled analysis of short-term studies in patients with major depressive disorder. Neuropsychiatric Disease and Treatment, 17, 575–585. doi:10.2147/NDT.S296451
   PubMed Web of Science ®Google Scholar
• Meltzer, H. Y., Alphs, L., Green, A. I., Altamura, A. C., Anand, R., Bertoldi, A., Bourgeois, M., Chouinard, G., Islam, M. Z., Kane, J., Krishnan, R., Lindenmayer, J. P., Potkin, S., & International Suicide Prevention Trial Study Group (2003). Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry, 60(1), 82–91. doi:10.1001/archpsyc.60.1.82
   PubMed Web of Science ®Google Scholar
• Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. The British Journal of Psychiatry, 134, 382–389. doi:10.1192/bjp.134.4.382
   PubMed Web of Science ®Google Scholar
• Murrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., Aan Het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013). Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biological Psychiatry, 74(4), 250–256. doi:10.1016/j.biopsych.2012.06.022
   PubMed Web of Science ®Google Scholar
• Nock, M. K., Borges, G., Bromet, E. J., Alonso, J., Angermeyer, M., Beautrais, A., Bruffaerts, R., Chiu, W. T., de Girolamo, G., Gluzman, S., de Graaf, R., Gureje, O., Haro, J. M., Huang, Y., Karam, E., Kessler, R. C., Lepine, J. P., Levinson, D., Medina-Mora, M. E., … Williams, D. (2008). Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. The British Journal of Psychiatry, 192(2), 98–105. doi:10.1192/bjp.bp.107.040113
   PubMed Web of Science ®Google Scholar
• Price, R. B., Iosifescu, D. V., Murrough, J. W., Chang, L. C., Al Jurdi, R. K., Iqbal, S. Z., Soleimani, L., Charney, D. S., Foulkes, A. L., & Mathew, S. J. (2014). Effects of ketamine on explicit and implicit suicidal cognition: A randomized controlled trial in treatment-resistant depression. Depression and Anxiety, 31(4), 335–343. doi:10.1002/da.22253
   PubMed Web of Science ®Google Scholar
• Shiroma, P. R., Johns, B., Kuskowski, M., Wels, J., Thuras, P., Albott, C. S., & Lim, K. O. (2014). Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression. Journal of Affective Disorders, 155, 123–129. doi:10.1016/j.jad.2013.10.036
   PubMed Web of Science ®Google Scholar
• Snaith, R. P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., & Trigwell, P. (1995). A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. The British Journal of Psychiatry, 167(1), 99–103. doi:10.1192/bjp.167.1.99
   PubMed Web of Science ®Google Scholar
• Song, J., Sjölander, A., Joas, E., Bergen, S. E., Runeson, B., Larsson, H., Landén, M., & Lichtenstein, P. (2017). Suicidal behavior during lithium and valproate treatment: A within-individual 8-year prospective study of 50,000 patients with bipolar disorder. The American Journal of Psychiatry, 174(8), 795–802. doi:10.1176/appi.ajp.2017.16050542
   PubMed Web of Science ®Google Scholar
• Tondo, L., & Baldessarini, R. J. (2016). Suicidal behavior in mood disorders: Response to pharmacological treatment. Current Psychiatry Reports, 18(9), 88. doi:10.1007/s11920-016-0715-0
   PubMed Web of Science ®Google Scholar
• Treadway, M. T., & Zald, D. H. (2011). Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience and Biobehavioral Reviews, 35(3), 537–555. doi:10.1016/j.neubiorev.2010.06.006
   PubMed Web of Science ®Google Scholar
• Turecki, G., & Brent, D. A. (2016). Suicide and suicidal behaviour. Lancet, 387(10024), 1227–1239. doi:10.1016/S0140-6736(15)00234-2
   PubMed Web of Science ®Google Scholar
• Watson, D., Weber, K., Assenheimer, J. S., Clark, L. A., Strauss, M. E., & McCormick, R. A. (1995). Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. Journal of Abnormal Psychology, 104(1), 3–14. doi:10.1037/0021-843X.104.1.3
   PubMed Web of Science ®Google Scholar
• Wilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., Sos, P., Wang, G., Zarate, C. A., Jr., & Sanacora, G. (2018). The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data meta-analysis. The American Journal of Psychiatry, 175(2), 150–158. doi:10.1176/appi.ajp.2017.17040472
   PubMed Web of Science ®Google Scholar
• Winer, E. S., Drapeau, C. W., Veilleux, J. C., & Nadorff, M. R. (2016). The association between anhedonia, suicidal ideation, and suicide attempts in a large student sample. Archives of Suicide Research, 20(2), 265–272. doi:10.1080/13811118.2015.1025119
   PubMed Web of Science ®Google Scholar
• Winer, E. S., Nadorff, M. R., Ellis, T. E., Allen, J. G., Herrera, S., & Salem, T. (2014). Anhedonia predicts suicidal ideation in a large psychiatric inpatient sample. Psychiatry Research, 218(1–2), 124–128. doi:10.1016/j.psychres.2014.04.016
   PubMed Web of Science ®Google Scholar
• Xie, G. R., & Shen, Q. J. (1984). Use of the Chinese version of the Hamilton Rating Scale for Depression in general population and patients with major depression (In Chinese). Chinese Journal of Nervous and Mental Diseases, 10, 364.
   Google Scholar
• Xiong, J., Lipsitz, O., Chen-Li, D., Rosenblat, J. D., Rodrigues, N. B., Carvalho, I., Lui, L. M. W., Gill, H., Narsi, F., Mansur, R. B., Lee, Y., & McIntyre, R. S. (2021). The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. Journal of Psychiatric Research, 134, 57–68. doi:10.1016/j.jpsychires.2020.12.038
   PubMed Web of Science ®Google Scholar
• Zheng, W., Zhou, Y.-L., Liu, W.-J., Wang, C.-Y., Zhan, Y.-N., Li, H.-Q., Chen, L.-J., Li, M. D., & Ning, Y.-P. (2018). Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. Journal of Psychiatric Research, 106, 61–68. doi:10.1016/j.jpsychires.2018.09.013
   PubMed Web of Science ®Google Scholar
• Zheng, W., Zhou, Y.-L., Liu, W.-J., Wang, C.-Y., Zhan, Y.-N., Li, H.-Q., Chen, L.-J., Li, M. D., & Ning, Y.-P. (2019). Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder. Journal of Psychopharmacology, 33(4), 494–501. doi:10.1177/0269881119827811
   PubMed Web of Science ®Google Scholar
• Zheng, W., Zhou, Y. L., Wang, C. Y., Lan, X. F., Zhang, B., Zhou, S. M., Yan, S., Yang, M. Z., Nie, S., & Ning, Y. P. (2020). Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation. Therapeutic Advances in Psychopharmacology, 10, 2045125320973794. doi:10.1177/2045125320973794
   PubMed Web of Science ®Google Scholar
• Zhong, B. L., Wang, Y., Chen, H. H., & Wang, X. H. (2011). Reliability, validity and sensitivity of Montgomery-Åsberg Depression Rating Scale for patients with current major depressive disorder [in Chinese]. Chinese Journal of Behavioural Medicine and Brain Sciences, 20, 85–87.
   Google Scholar